Autologous ASC transplantation into the lacrimal gland appears to be a safe and promising therapeutic option for aqueous-deficient DED in SS, offering significant improvement in both objective measures and patient-reported symptoms over a 6-month period.
No takes yet. Share an insight, caveat, or question.
Mohammadpour et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: